Neuroleptic malignant syndrome (NMS) is a rare reaction to antipsychotic drugs that are used to treat schizophrenia, bipolar disorder, and other mental health conditions. It affects the nervous system ...
NMS Capital has promoted Daniel Schwartz to managing director and Jake Kinsley to vice president. Schwartz joined NMS in 2021 as a principal while Kinsley came on board in 2018 as an associate. New ...
NMS Capital has appointed Duffy to its operating executive council. In this role, Duffy will work to identify, partner with, and build industry leading businesses within the outsourced pharmaceutical ...
LOS ANGELES, CA / ACCESS Newswire / May 12, 2025 / NMS Capital Group ("NMS") is proud to announce its inclusion in the Los Angeles Business Journal's 2024 list of Top Private Equity Firms, published ...
HORSHAM, Pa.--(BUSINESS WIRE)--NMS Labs, one of the nation’s leading forensic science and bioanalytical toxicology laboratories, announced today that Dan T. Monahan is the now President and Chief ...
HORSHAM, Pa.--(BUSINESS WIRE)--NMS Labs announced today that David Delia has been selected as the new President and Chief Executive Officer of the Company. Mr. Delia will guide the organization’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results